Target intelligence / Profile preview

Aequorin

Molecular classification
Calcium-binding protein, EF-hand protein, Photoprotein, Bioluminescent protein
01

Overview

Aequorin is a bioluminescent photoprotein originally isolated from the jellyfish *Aequorea victoria*. It consists of a 21–22 kDa protein (apoaequorin) bound to the prosthetic group coelenterazine and contains three EF-hand calcium-binding motifs[3][4][8]. Upon binding three calcium ions, aequorin undergoes oxidation of coelenterazine to generate blue light, which is measured as an indicator of intracellular calcium concentration changes[3][8]. Aequorin is widely used as a highly sensitive, non-invasive reporter of intracellular calcium dynamics in living cells and organisms across diverse systems (plants, fungi, animals)[3][5][7]. It acts as an *orthogonal* (non-interfering with host cell pathways) calcium sensor, as it does not bind mammalian calcium signaling components[1]. Fusion reporters combining aequorin with fluorescent proteins (e.g., GFP–aequorin) produce sensors with dual bioluminescence/fluorescence properties to enhance calcium detection[1][2]. Because it is not a human protein or disease-related target, and is instead a reporter tool, it is inappropriate to designate it as a canonical therapeutic target, receptor, or drug interaction site.

Other names
apoaequorinPhotoprotein aequorinCalcium-activated photoprotein
02

Biological functions

Calcium ion detectionCalcium homeostasis assayIntracellular calcium signaling marker

Beyond the preview

Go deeper on Aequorin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aequorin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call